Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inotiv, Inc.
  6. News
  7. Summary
    NOTV   US45783Q1004

INOTIV, INC.

(NOTV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inotiv : Buys MilliporeSigma's Genetic Toxicology Assets

07/12/2021 | 10:10am EDT


ę MT Newswires 2021
All news about INOTIV, INC.
09/14INOTIV, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/14Inotiv, Inc. Terminates Employment of Joseph E. Flynn as Chief Commercial Off..
CI
08/31INOTIV : to Participate in the 2021 Colliers Institutional Investor Conference
AQ
08/18INOTIV : 3rd Qtr 10Q
PU
08/13INOTIV : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
08/11INOTIV : Announces Third Quarter Fiscal 2021 Financial Results (Form 8-K)
PU
08/11INOTIV, INC. : Results of Operations and Financial Condition, Financial Statemen..
AQ
08/11INOTIV : Earnings Flash (NOTV) INOTIV Reports Q3 Revenue $22.9M, vs. Street Est ..
MT
08/11INOTIV : Announces Third Quarter Fiscal 2021 Financial Results
AQ
08/10INOTIV : Financial Statements and Exhibits (form 8-K/A)
AQ
More news
Analyst Recommendations on INOTIV, INC.
More recommendations
Financials (USD)
Sales 2021 84,0 M - -
Net income 2021 -5,15 M - -
Net Debt 2021 - - -
P/E ratio 2021 -94,8x
Yield 2021 -
Capitalization 558 M 558 M -
Capi. / Sales 2021 6,65x
Capi. / Sales 2022 4,31x
Nbr of Employees 409
Free-Float 62,5%
Chart INOTIV, INC.
Duration : Period :
Inotiv, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INOTIV, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 35,09 $
Average target price 38,00 $
Spread / Average Target 8,29%
EPS Revisions
Managers and Directors
Robert Leasure President, Chief Executive Officer & Director
Beth A. Taylor Chief Financial Officer, Secretary & VP-Finance
Gregory C. Davis Chairman
John Gregory Beattie Chief Operating Officer
Richard Allen Johnson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INOTIV, INC.0.00%558
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420